Reduced incidence of lung cancer in patients with idiopathic pulmonary fibrosis treated with pirfenidone

Y Miura, T Saito, T Tanaka, H Takoi, Y Yatagai… - Respiratory …, 2018 - Elsevier
Background Idiopathic pulmonary fibrosis (IPF) is a disease with a worse prognosis than some
types of cancer. In patients with IPF, lung cancer is critical because of the associated high …

Clinical experience with pirfenidone in five patients with scleroderma-related interstitial lung disease.

…, K Fujita, Y Tsunoda, T Tanaka, H Takoi… - … Vasculitis, and Diffuse …, 2014 - europepmc.org
Interstitial lung disease is the most common complication and cause of death among patients
with scleroderma. Scleroderma-related interstitial lung disease has usually been treated …

[HTML][HTML] Corticosteroids for hospitalized patients with mild to critically-ill COVID-19: a multicenter, retrospective, propensity score-matched study

…, T Yamaguchi, K Iwabuchi, M Masuda, H Takoi… - Scientific reports, 2021 - nature.com
Corticosteroids use in coronavirus disease 2019 (COVID-19) is controversial, especially in
mild to severe patients who do not require invasive/noninvasive ventilation. Moreover, many …

Polymyxin B haemoperfusion treatment for respiratory failure and hyperferritinaemia due to COVID‐19

M Ishiwari, Y Togashi, H Takoi, R Kikuchi… - Respirology Case …, 2020 - Wiley Online Library
A 69‐year‐old man with a history of type 2 diabetes and high blood pressure was diagnosed
with coronavirus disease 2019 (COVID‐19). He had hyperferritinaemia and respiratory …

Central nervous system manifestations of tuberculosis-associated immune reconstitution inflammatory syndrome during adalimumab therapy: a case report and …

T Tanaka, A Sekine, Y Tsunoda, H Takoi, SY Lin… - Internal …, 2015 - jstage.jst.go.jp
A 64-year-old neurologically asymptomatic woman with rheumatoid arthritis who was treated
with the tumor necrosis factor (TNF)-α antagonist adalimumab developed disseminated …

Glasgow prognostic score predicts chemotherapy‐triggered acute exacerbation‐interstitial lung disease in patients with non‐small cell lung cancer

R Kikuchi, H Takoi, T Tsuji, Y Nagatomo… - Thoracic …, 2021 - Wiley Online Library
Background Interstitial lung disease (ILD) in patients with non‐small cell lung cancer (NSCLC)
worsens the prognosis for overall survival (OS) due to chemotherapy‐triggered acute …

[HTML][HTML] Favipiravir-induced fever in coronavirus disease 2019: a report of two cases

H Takoi, Y Togashi, D Fujimori, H Kaizuka… - International Journal of …, 2020 - Elsevier
Favipiravir, an antiviral agent, is undergoing clinical trials for treating novel coronavirus disease
2019 (COVID-19). Here, we report two cases of COVID-19 with favipiravir-induced fever. …

Impact of sarcopenia on chemotherapy‐triggered exacerbation of interstitial lung disease in patients with non‐small cell lung cancer

R Kikuchi, H Takoi, M Ishiwari, K Toriyama… - Thoracic …, 2022 - Wiley Online Library
Background While recent evidence has suggested that sarcopenia could predict chemotoxicity,
its association with chemotherapy‐triggered interstitial lung disease (ILD) exacerbations …

[HTML][HTML] Anti-MDA5 antibody-positive rapidly progressive interstitial pneumonia without cutaneous manifestations

J Aoyama, H Hayashi, C Yajima, H Takoi… - … medicine case reports, 2019 - Elsevier
A 47-year-old man was referred to our hospital with a 1-month history of fever and dyspnea
after inhalation of insecticide in a confined space. We diagnosed rapidly progressive …

Surfactant protein D: A useful biomarker for distinguishing COVID‐19 pneumonia from COVID‐19 pneumonia‐like diseases

…, K Toriyama, R Kikuchi, H Takoi… - Health Science …, 2022 - Wiley Online Library
Introduction Computed tomography is useful for the diagnosis of coronavirus disease (COVID‐19)
pneumonia. However, many types of interstitial lung diseases and even bacterial …